Quiz: Fertility Preservation Possible in Stage I Ovarian Cancer?

October 1, 2017

What are secondary adjuvant therapy options for stages II–IV ovarian cancer patients in complete remission? And do you know if fertility preservation is possible in patients with stage I ovarian cancer? Test your knowledge on these topics and more in our latest quiz.

What are secondary adjuvant therapy options for stages II–IV ovarian cancer patients in complete remission? And do you know if fertility preservation is possible in patients with stage I ovarian cancer? Test your knowledge on these topics and more in our latest quiz.

Question 1

Answer

B. 1.3%. According to the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program data, approximately 1.3% of women will be diagnosed with ovarian cancer at some point during their lifetime.

Question 2

Answer

B.22,440. According to SEER Program data, an estimated 22,440 women will be newly diagnosed with ovarian cancer in 2017.

Question 3

Answer

A.True. According to the National Comprehensive Cancer Network (NCCN) 2017 Guidelines, if fertility preservation is desired, clinical stage IA ovarian cancer should be treated with unilateral salpingo-oophorectomy plus comprehensive surgical staging, and clinical stage IB disease should be treated with bilateral salpingo-oophorectomy plus comprehensive surgical staging.

Question 4

Answer

B.39%. According to the most recent estimates by the National Cancer Institute, 39% of women who inherit a BRCA1 mutation and 11% to 17% of women who inherit a BRCA2 mutation will develop ovarian cancer by 70 years of age.

Question 5

Answer

D.Carboplatin. According to the NCCN 2017 Guidelines, secondary adjuvant therapy options include clinical trials, observation with follow-up monitoring, and treatment with pazopanib.